Triple-negative or basal-like breast cancers, which are defined as breast cancer without expression of ER, PR and human epidermal growth factor receptor 2 (HER2), are found to be associated with shorter time to recurrence and higher metastatic potentials [4–6]. Here, ERBB2 is linked to breast carcinoma.